What to Watch Today

Matt Bomer's Tycoon, OITNB Returns, Sigmund and More

On TV this Friday: Amazon samples Matt Bomer’s Last role, Orange Is the New Black deals with overpopulation and Chelsea gets an assist from TV’s funniest Moms. Here are 10 programs to keep on your radar:

  • Netflix
    Orange Is the New Black

    Season 4 premiere (all 13 episodes): Racial tensions rise when Litchfield becomes overpopulated with an obscene amount of new inmates. (Get renewal status.)

  • Amazon Prime
    The Last Tycoon

    Pilot preview: Matt Bomer (White Collar) fronts this F. Scott Fitzgerald adaptation, playing a Hollywood golden boy battling a father figure (Kelsey Grammer) for the soul of their studio; Lily Collins (The Blind Side) co-stars.

  • Amazon
    The Interestings

    Pilot preview: Lauren Ambrose (Six Feet Under) portrays an actress who lacks the talent to make it big; David Krumholtz (Numb3rs), Jessica Pare (Mad Men) and Matt Barr (Sleepy Hollow) co-star.

  • Amazon
    Sigmund and the Sea Monsters

    Pilot preview: The premium streaming network debuts its reimagining of Sid and Marty Krofft’s live-action 1970s kids show. (Get details.)

  • Netflix

    Guests include Mom‘s Anna Faris and Allison Janney, who assist Handler with an anti-child PSA, and political commentator Keith Olbermann.

  • Disney Channel
    Girl Meets World

    Riley learns high school test scores count towards her permanent record when she receives her first bad grade. (Get casting news.)

  • ESPN
    30 for 30: O.J. Made in America

    Part 4 of 5: As the murder trial of the century gets underway, the media landscape is forever changed.

  • Cinemax

    Kyle and Reverend Anderson face an unusual possession. (Catch up with recaps of Episodes 1 and 2.)

  • Syfy
    Wynonna Earp

    Wynonna tries to outsmart Bobo Del Rey and keep Dolls safe; the town’s safety is jeopardized by a vengeful new threat. (Get “Date Night” scoop!)

  • HBO

    The newsmagazine explores how the money raised by the ALS Ice Bucket Challenge paved the way for new research into the neurodegenerative disease.